CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 10 enrolled
Drug / intervention
Morphinedrug
Likely dose
Morphine 30 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04342130
NCT04342130Phase 4Completed
CompareCT.gov

Brain Effects of Opiate Agonist and Antagonist

University of Rochester·interventional·Posted Apr 10, 2020·Updated May 7, 2021

In Brief

A Phase 4 clinical trial evaluating Morphine for Chronic Low-back Pain. Completed, enrolled 10 participants across 1 site.

Detailed Summary

This study will look at the short-term effect of morphine on brain response to food.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Low-back Pain
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
20192020202120222023202420252026
First PostedApr 10, 2020
Enrollment StartApr 27, 2018
Primary CompletionApr 16, 2019
TodayJul 2, 2026
Enrollment to primary: 12 monthsPosted 6.2 years ago

Interventions

Morphinedrug

30 mg oral tablet